National Institutes of Health (NIH): Examination of Survivorship Care Planning Efficacy and Impact (R21)

This opportunity uses the R21 Exploratory/Developmental Research Grants funding mechanism.

This Funding Opportunity Announcement (FOA) aims to stimulate research to evaluate the effect of care planning on cancer survivors’ health and psycho-social outcomes; self-management of late effects and adherence to cancer screening and health behaviour guidelines; utilisation of follow-up care; organisational-level factors influencing the implementation of care planning; and associated costs.

Specifically, the FOA aims to stimulate research that will:

  • develop and test metrics for evaluating the impact of survivorship care planning;
  • evaluate the impact of survivorship care planning on cancer survivors’ morbidity, self-management and adherence to care recommendations, utilisation of follow-up care, and on systems outcomes, such as associated costs and impact on organizations implementing care planning; and
  • identify models and processes of care that promote effective survivorship care planning.

The ultimate goal of this FOA is to generate a body of science that will inform the development and delivery of interventions and best practices in follow-up care for cancer survivors.

Companion Schemes

Funding & Duration

The combined budget for direct costs for the two-year project period may not exceed US $275,000 (AUD $380,000). No more than $200,000 (AUD $276,000) may be requested in any single year.

The maximum project period is 2 years.


Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply.

Submission Requirements

Further Information

This entry was posted in Arts, Engineering, Computer & Mathematical Sciences, Funding by Award Type, Grants (Project Funds), Health & Medical Sciences, International Funding, Professions and tagged . Bookmark the permalink.

Comments are closed.